Agilent Technologies, Inc. (NYSE:A) Shares Sold by Yousif Capital Management LLC

Yousif Capital Management LLC cut its position in Agilent Technologies, Inc. (NYSE:A) by 4.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 34,329 shares of the medical research company’s stock after selling 1,605 shares during the quarter. Yousif Capital Management LLC’s holdings in Agilent Technologies were worth $4,773,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also modified their holdings of the company. Carmel Capital Partners LLC grew its stake in Agilent Technologies by 1.2% during the 4th quarter. Carmel Capital Partners LLC now owns 6,709 shares of the medical research company’s stock worth $933,000 after purchasing an additional 78 shares in the last quarter. Kepos Capital LP grew its stake in Agilent Technologies by 3.5% during the 3rd quarter. Kepos Capital LP now owns 2,775 shares of the medical research company’s stock worth $310,000 after purchasing an additional 93 shares in the last quarter. Rosenberg Matthew Hamilton grew its stake in Agilent Technologies by 51.1% during the 4th quarter. Rosenberg Matthew Hamilton now owns 284 shares of the medical research company’s stock worth $39,000 after purchasing an additional 96 shares in the last quarter. Invesco LLC grew its stake in Agilent Technologies by 0.7% during the 3rd quarter. Invesco LLC now owns 15,471 shares of the medical research company’s stock worth $1,730,000 after purchasing an additional 101 shares in the last quarter. Finally, Balentine LLC grew its stake in Agilent Technologies by 3.4% during the 3rd quarter. Balentine LLC now owns 3,180 shares of the medical research company’s stock worth $356,000 after purchasing an additional 104 shares in the last quarter. 87.42% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, VP Rodney Gonsalves sold 4,828 shares of the company’s stock in a transaction that occurred on Thursday, March 7th. The stock was sold at an average price of $149.00, for a total value of $719,372.00. Following the sale, the vice president now owns 21,329 shares of the company’s stock, valued at approximately $3,178,021. The transaction was disclosed in a filing with the SEC, which is available through this link. In related news, VP Rodney Gonsalves sold 4,828 shares of the company’s stock in a transaction that occurred on Thursday, March 7th. The stock was sold at an average price of $149.00, for a total value of $719,372.00. Following the sale, the vice president now owns 21,329 shares of the company’s stock, valued at approximately $3,178,021. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO Michael R. Mcmullen sold 52,297 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $150.00, for a total value of $7,844,550.00. Following the completion of the sale, the chief executive officer now directly owns 253,909 shares in the company, valued at approximately $38,086,350. The disclosure for this sale can be found here. Insiders have sold a total of 61,610 shares of company stock worth $9,220,333 in the last quarter. Company insiders own 0.33% of the company’s stock.

Agilent Technologies Stock Performance

NYSE A opened at $137.69 on Friday. The company has a current ratio of 2.68, a quick ratio of 2.04 and a debt-to-equity ratio of 0.41. The business’s 50 day moving average is $141.59 and its two-hundred day moving average is $130.56. Agilent Technologies, Inc. has a 12-month low of $96.80 and a 12-month high of $151.58. The stock has a market capitalization of $40.35 billion, a price-to-earnings ratio of 32.78, a PEG ratio of 4.17 and a beta of 1.11.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Tuesday, February 27th. The medical research company reported $1.29 earnings per share for the quarter, topping analysts’ consensus estimates of $1.22 by $0.07. The business had revenue of $1.66 billion for the quarter, compared to analysts’ expectations of $1.59 billion. Agilent Technologies had a return on equity of 27.09% and a net margin of 18.35%. The company’s revenue was down 5.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.37 EPS. Research analysts expect that Agilent Technologies, Inc. will post 5.5 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, April 24th. Investors of record on Tuesday, April 2nd were issued a $0.236 dividend. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.69%. The ex-dividend date was Monday, April 1st. Agilent Technologies’s dividend payout ratio is currently 22.38%.

Wall Street Analysts Forecast Growth

A has been the subject of a number of recent analyst reports. Evercore ISI lifted their price target on Agilent Technologies from $132.00 to $145.00 and gave the stock an “in-line” rating in a report on Thursday, April 4th. Barclays lifted their price target on Agilent Technologies from $125.00 to $135.00 and gave the stock an “underweight” rating in a report on Wednesday, April 10th. Stifel Nicolaus upgraded Agilent Technologies from a “hold” rating to a “buy” rating and boosted their price target for the company from $145.00 to $163.00 in a research report on Friday, April 5th. Citigroup boosted their price target on Agilent Technologies from $130.00 to $145.00 and gave the company a “neutral” rating in a research report on Wednesday, February 28th. Finally, Oppenheimer boosted their price target on Agilent Technologies from $67.00 to $90.00 and gave the company an “outperform” rating in a research report on Tuesday, March 26th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $141.29.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.